RYPMX
Price
$262.58
Change
-$1.29 (-0.49%)
Updated
Dec 3 closing price
Net Assets
164.6M
SGGDX
Price
$53.78
Change
-$0.27 (-0.50%)
Updated
Dec 3 closing price
Net Assets
5.13B
Interact to see
Advertisement

RYPMX vs SGGDX

Header iconRYPMX vs SGGDX Comparison
Open Charts RYPMX vs SGGDXBanner chart's image
Rydex Precious Metals I
Price$262.58
Change-$1.29 (-0.49%)
VolumeN/A
Net Assets164.6M
First Eagle Gold A
Price$53.78
Change-$0.27 (-0.50%)
VolumeN/A
Net Assets5.13B
RYPMX vs SGGDX Comparison Chart in %
View a ticker or compare two or three
VS
RYPMX vs. SGGDX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYPMX is a StrongBuy and SGGDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SGGDX has more cash in the bank: 5.13B vs. RYPMX (165M). SGGDX pays higher dividends than RYPMX: SGGDX (2.44) vs RYPMX (0.00). RYPMX was incepted earlier than SGGDX: RYPMX (32 years) vs SGGDX (32 years). RYPMX (1.34) is less costly to investors than SGGDX (1.16). RYPMX is a more actively managed with annual turnover of: 452.00 vs. SGGDX (60.97). RYPMX (2500) and SGGDX (2500) have matching initial minimum investment requirements. RYPMX annual gain was more profitable for investors over the last year : 120.09 vs. SGGDX (103.34). SGGDX return over 5 years is better than : 134.84 vs. RYPMX (104.81).
RYPMXSGGDXRYPMX / SGGDX
Total Expense Ratio1.291.16111%
Annual Report Gross Expense Ratio1.341.16116%
Fund Existence32 years32 years-
Gain YTD137.830116.285119%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets165M5.13B3%
Annual Yield % from dividends0.002.44-
Returns for 1 year120.09103.34116%
Returns for 3 years146.81153.3196%
Returns for 5 years104.81134.8478%
Returns for 10 years398.19386.64103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSJX26.83N/A
N/A
MFS Research International R4
AHSCX13.95N/A
N/A
Alger Health Sciences C
NGDRX33.61N/A
N/A
Neuberger Berman Large Cap Growth R3
HADRX85.15N/A
N/A
Horizon Defined Risk Advisor
GMAZX18.36N/A
N/A
GMO International Opportunistic Val IV